Asthma in patients with coronavirus disease 2019: A systematic review and meta-analysis.

ABSTRACT:

Background

It is unclear whether asthma has an influence on contracting coronavirus disease 2019 (COVID-19) or having worse outcomes from COVID-19 disease.

Objective

To explore the prevalence of asthma in patients with COVID-19 and the relationship between asthma and patients with COVID-19 with poor outcomes.

Methods

The pooled prevalence of asthma in patients with COVID-19 and corresponding 95% confidence interval (CI) were estimated. The pooled effect size (ES) was used to evaluate the association between asthma and patients with COVID-19 with poor outcomes.

Results

The pooled prevalence of asthma in patients with COVID-19 worldwide was 8.3% (95% CI, 7.6-9.0) based on 116 articles (119 studies) with 403,392 cases. The pooled ES based on unadjusted effect esti

SUBMITTER: Shi L 

PROVIDER: S-EPMC7889465 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature